Literature DB >> 9931201

Experimental neonatal respiratory failure induced by lysophosphatidylcholine: effect of surfactant treatment.

G Grossmann1, K Tashiro, T Kobayashi, Y Suzuki, Y Matsumoto, Y Waseda, T Akino, T Curstedt, B Robertson.   

Abstract

The purpose of this study was to characterize the toxic effects of lysophosphatidylcholine (lyso-PC) on neonatal lung function. Various doses of lyso-PC (from 0 to 40 mg/kg) were administered to near-term newborn rabbits. Lung-thorax compliance during mechanical ventilation was significantly decreased by doses >/=10 mg/kg, and static lung volumes during deflation were decreased by doses >/=20 mg/kg. Using the same experimental model, we investigated the effects of modified porcine surfactant (Curosurf, 200 mg/kg). Animals exposed to lyso-PC at birth and treated simultaneously with surfactant showed a satisfactory therapeutic response, whereas those treated after 30 min failed to respond. These animals also had a much larger leak of albumin into the air spaces and an elevated minimum surface tension of the lavage fluid in a pulsating bubble surfactometer, suggesting inactivation of the exogenous surfactant. Timing of surfactant administration may thus be essential for the therapeutic effect in this experimental model of acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931201     DOI: 10.1152/jappl.1999.86.2.633

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  4 in total

1.  Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.

Authors:  Daniele De Luca; Angelo Minucci; Enrico Zecca; Marco Piastra; Domenico Pietrini; Virgilio P Carnielli; Cecilia Zuppi; Ascanio Tridente; Giorgio Conti; Ettore D Capoluongo
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

2.  Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia.

Authors:  Nancy B Ray; Lakshmi Durairaj; Bill B Chen; Bryan J McVerry; Alan J Ryan; Michael Donahoe; Alisa K Waltenbaugh; Christopher P O'Donnell; Florita C Henderson; Christopher A Etscheidt; Diann M McCoy; Marianna Agassandian; Emily C Hayes-Rowan; Tiffany A Coon; Phillip L Butler; Lokesh Gakhar; Satya N Mathur; Jessica C Sieren; Yulia Y Tyurina; Valerian E Kagan; Geoffrey McLennan; Rama K Mallampalli
Journal:  Nat Med       Date:  2010-09-19       Impact factor: 53.440

3.  Lipidomics reveals dramatic lipid compositional changes in the maturing postnatal lung.

Authors:  Sydney E Dautel; Jennifer E Kyle; Geremy Clair; Ryan L Sontag; Karl K Weitz; Anil K Shukla; Son N Nguyen; Young-Mo Kim; Erika M Zink; Teresa Luders; Charles W Frevert; Sina A Gharib; Julia Laskin; James P Carson; Thomas O Metz; Richard A Corley; Charles Ansong
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

4.  Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia.

Authors:  Kelvin K W To; Kim-Chung Lee; Samson S Y Wong; Kong-Hung Sze; Yi-Hong Ke; Yin-Ming Lui; Bone S F Tang; Iris W S Li; Susanna K P Lau; Ivan F N Hung; Chun-Yiu Law; Ching-Wan Lam; Kwok-Yung Yuen
Journal:  Diagn Microbiol Infect Dis       Date:  2016-03-14       Impact factor: 2.803

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.